Cholecystokinin octapeptide, proglumide, and passive avoidance in rats

Area of Science:

• Neuroscience
• Behavioral Pharmacology
• Animal Models

Background:

• Passive avoidance behavior is a crucial learning and memory process.
• Cholecystokinin (CCK) peptides are implicated in various cognitive functions, including learning and memory.
• The role of endogenous CCK in passive avoidance conditioning remains to be fully elucidated.

Purpose of the Study:

• To investigate the effect of Cholecystokinin octapeptide (CCK-8) on passive avoidance behavior in rats.
• To determine if CCK-8 administration influences the latency to enter a conditioned avoidance chamber.
• To examine the potential modulatory role of CCK-8 antagonism on passive avoidance conditioning.

Main Methods:

• Rats were conditioned to avoid a darkened chamber using electric footshock.
• Injections of CCK-8, the CCK-8 antagonist proglumide, or saline were administered post-conditioning.
• Passive avoidance behavior was assessed by measuring the latency to enter the dark chamber one day after training.

Main Results:

• CCK-8 administration significantly reduced passive avoidance latency in a dose-dependent manner (30-500 µg/kg).
• Proglumide (5 mg/kg) effectively blocked the amnesic effects of CCK-8 on passive avoidance.
• Proglumide alone (2 mg/kg) also decreased avoidance latency, suggesting a role for endogenous CCK.

Conclusions:

• Endogenous CCK-8 activity appears to be involved in the neural mechanisms underlying passive avoidance conditioning in rats.
• CCK-8 administration disrupts passive avoidance learning, potentially through modulation of fear memory consolidation or retrieval.
• Pharmacological manipulation of the CCK system offers a potential avenue for understanding and influencing aversive learning.